High Risk Hepatocellular Carcinoma Hcc clinical trials

Explore recruiting high risk hepatocellular carcinoma hcc clinical trials.

Recruiting high risk hepatocellular carcinoma hcc studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

High Risk Hepatocellular Carcinoma Hcc trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase III, Multicenter, Randomized, Open-Label Study of Atezolizumab (Anti-PD-L1 Antibody) Plus Bevacizumab Versus Active Surveillance as Adjuvant Therapy in Patients with Hepatocellular Carcinoma at High Risk of Recurrence After Surgical Resection or Ablation

Czechia, Germany, Italy, Spain, France, Belgium +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

High Risk Hepatocellular Carcinoma Hcc trials by city

High Risk Hepatocellular Carcinoma Hcc in Toronto High Risk Hepatocellular Carcinoma Hcc in Vancouver High Risk Hepatocellular Carcinoma Hcc in Montreal High Risk Hepatocellular Carcinoma Hcc in Calgary High Risk Hepatocellular Carcinoma Hcc in Edmonton High Risk Hepatocellular Carcinoma Hcc in Ottawa High Risk Hepatocellular Carcinoma Hcc in Winnipeg High Risk Hepatocellular Carcinoma Hcc in Quebec City High Risk Hepatocellular Carcinoma Hcc in Hamilton High Risk Hepatocellular Carcinoma Hcc in Kitchener High Risk Hepatocellular Carcinoma Hcc in London High Risk Hepatocellular Carcinoma Hcc in Halifax High Risk Hepatocellular Carcinoma Hcc in New York High Risk Hepatocellular Carcinoma Hcc in Los Angeles High Risk Hepatocellular Carcinoma Hcc in Chicago High Risk Hepatocellular Carcinoma Hcc in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease